Skip to main content

Table 2 Comparison of Treg subpopulations, LAP+CD11b+ monocytes, and TGF-β between proliferative and secretory phases in each group (mean ± SD)

From: Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis

Peritoneal fluid
  Phase rTregs (%) P eTregs (%) P nonTregs (%) P LAP+CD11b + Macrophages P TGF-β P
Endometriosis Proliferative (n = 12) 0.73 ± 0.56 ns 3.9 ± 1.7 ns 7.7 ± 2.7 ns 13.0 ± 14.4 ns 1.12 ± 0.57 ns
Secretory (n = 16) 0.82 ± 0.75 3.1 ± 2.8 6.0 ± 3.0 12.1 ± 16.4 1.09 ± 0.32
Control Proliferative (n = 10) 0.47 ± 0.60 ns 2.2 ± 1.5 ns 5.8 ± 2.1 ns 80.0 ± 19.7 ns 0.85 ± 0.26 ns
Secretory (n = 10) 0.30 ± 0.24 1.8 ± 1.3 8.6 ± 1.6 81.3 ± 17.3 0.79 ± 0.26
Peripheral blood
  Phase rTregs (%) P eTregs (%) P nonTregs (%) P LAP+CD11b + Monocytes P   
Endometriosis Proliferative (n = 12) 1.3 ± 0.61 ns 1.2 ± 2.2 ns 2.4 ± 1.9 ns 83.5 ± 16.7 ns   
Secretory (n = 16) 2.1 ± 1.6 0.9 ± 1.0 3.0 ± 1.8 80.3 ± 19.7   
Control Proliferative (n = 10) 1.3 ± 2.6 ns 1.2 ± 0.8 ns 4.4 ± 2.6 ns 79.2 ± 19.1 ns   
Secretory (n = 10) 0.8 ± 2.8 0.8 ± 0.4 3.9 ± 2.2 85.9 ± 11.5   
  1. Differences between groups were analyzed by Mann-Whitney U-tests. ns, not significant